An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients
- Status
- UNKNOWN
- Phase
- PHASE4
Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
Changes in the Gut Microbiota of Patients Undergoing Allogeneic Stem Cell Transplantation (COLLECT)
- Status
- UNKNOWN
- Phase
- N/A
Study of AMV564 in Patients With AML
- Status
- COMPLETED
- Phase
- PHASE1
Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults
- Status
- TERMINATED
- Phase
- PHASE1
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Activity of Digoxin With Decitabine in Adult AML and MDS
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Gluten Free Diet in Diminishing Side Effects Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide
- Status
- TERMINATED
- Phase
- PHASE2
Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal Karyotype
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2